Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma

Published:2018-01 Issue: Volume:97 Page:195-202
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Wu Dong-hao,Wang Tian-Tian,Ruan Dan-Yun,Li Xing,Chen Zhan-Hong,Wen Jing-Yun,Lin Qu,Ma Xiao-Kun,Wu Xiang-yuan,Jia Chang-Chang

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference36 articles.

1. Hepatocellular carcinoma epidemiology;Bosetti;Best Pract. Res. Clin. Gastroenterol.,2014

2. Liver transplantation: an update, 2009;Skagen;Curr. Opin. Gastroenterol.,2009

3. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

4. Surgery for malignant liver tumors;Shukla;J. Cancer Res. Ther.,2009

5. Retraction statement: the deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically-induced liver carcinogenesis;Hepatology,2013

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma;Oncogenesis;2024-09-12

2. Substituted indole derivatives as UNC-51-like kinase 1 inhibitors: Design, synthesis and anti-hepatocellular carcinoma activity;Biomedicine & Pharmacotherapy;2024-09

3. Tumor biomarkers for diagnosis, prognosis and targeted therapy;Signal Transduction and Targeted Therapy;2024-05-20

4. The clinicopathological significance and potential function of ULK1 in colon cancer;Biotechnology and Genetic Engineering Reviews;2023-05-16

5. Autophagy orchestrates resistance in hepatocellular carcinoma cells;Biomedicine & Pharmacotherapy;2023-05